TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Alkermes, Inc. investor investigation over possible securities laws violations

  • If you are an investor in shares of Alkermes, Inc. (NASDAQ:ALKS), and/or have any information relating to the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

After Alkermes, Inc. lost more than 30% in stock value an investigation on behalf of investors in Alkermes, Inc. (NASDAQ:ALKS) shares concerning potential violations of Federal Securities laws in connection with the New Drug Application for Alkermess diabetes drug BYDUREON was announced. The investigation by a law firm on behalf of investors in ALKS shares concerns whether Alkermes, ...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: